Quest PharmaTech Inc. (QPT.V)
TSXV · CAD · Healthcare · Biotechnology
CA$0.02 (+0.00%) as of
Key statistics
- Market cap
- 3.38M
- P/E (TTM)
- 0.67
- EPS (TTM)
- 0.0300
- Dividend yield
- 0.00%
- 52-week range
- 0.0200 – 0.0500
- Beta
- -0.46
- Profit margin
- 0.00%
- Volume
- 100.00
About Quest PharmaTech Inc.
Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company is headquartered in Edmonton, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Edmonton, AB, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.